Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.
- 1 June 1986
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 83 (12) , 4147-4151
- https://doi.org/10.1073/pnas.83.12.4147
Abstract
Four monoclonal antibodies were identified by their ability to bind to 125I-labeled insulin covalently linked to a cytosolic insulin-degrading enzyme from human erythrocytes. All four antibodies were also found to remove more than 90% of the insulin-degrading activity from erythrocyte extracts. These antibodies were shown to be directed to different sites on the enzyme by mapping studies and their various properties. Two antibodies recognized the insulin-degrading enzyme from rat liver; one inhibited the erythrocyte enzyme directly; and two recognized the enzyme after gel electrophoresis and transfer to nitrocellulose filters. By this latter procedure and immunoprecipitation from metabolically labeled cells, the enzyme from a variety of tissues was shown to be composed of a single polypeptide chain of apparent Mr 110,000. Finally, these monoclonal antibodies were microinjected into the cytoplasm of a human hepatoma cell line to assess the contribution of this enzyme to insulin degradation in the intact cell. In five separate experiments, preloading of cells with these monoclonal antibodies resulted in an inhibition of insulin degradation of 18-54% (average 39%) and increased the amount of 125I-labeled insulin associated with the cells. In contrast, microinjection of control antibody or an extraneous monoclonal antibody had no effect on insulin degradation or on the amount of insulin associated with the cells. Moreover, the monoclonal antibodies to the insulin-degrading enzyme caused no significant inhibition of degradation of another molecule, low density lipoprotein. Thus, these results support a role for this enzyme in insulin degradation in the intact cell.This publication has 42 references indexed in Scilit:
- Uptake and degradation of insulin and α2-macroglobulin-trypsin complex in rat adipocytes. Evidence for different pathwaysBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Production and characterization of a monoclonal antibody to rat liver thiol: Protein-disulfide oxidoreductase/glutathione-insulin transhydrogenaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984
- Insulin degradation by human skeletal muscleBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Studies of the properties of the insulin protease of rat liverBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- Diabetes Responsive to Intravenous but Not Subcutaneous Insulin: Effectiveness of AprotininNew England Journal of Medicine, 1981
- Apparent Insulin Resistance due to Abnormal Enzymatic Insulin Degradation: A New Mechanism for Insulin ResistanceAustralian and New Zealand Journal of Medicine, 1980
- Purification to Homogeneity of an Insulin-Degrading Enzyme from Human ErythrocytesHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1980
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Accelerated Insulin Degradation: An Alternate Mechanism for Insulin ResistanceDiabetes Care, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970